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In a number of clinical conditions such as intoxications, bacteremia or autoimmune diseases 
the removal of the disease-causing factor from blood would be the most direct cure. However, 
physicochemical characteristics of the target compounds limit the applicability of classical 
filtration and diffusion-based processes. In this work, we present a first in vivo magnetic 
blood purification rodent animal model and demonstrate its ability to rapidly clear toxins from 
blood circulation using two model toxins with stable plasma levels (lead ions and digoxin). 
Ultra-strong functionalized metal nanomagnets are employed to eliminate the toxin from 
whole blood in an extracorporeal circuit. After capturing the target substance, a magnetic trap 
prevents that the toxin-loaded nanoparticles enter the blood circulation. In the present 
experimental demonstration over 40% of the toxin (i.e. lead or digoxin) was removed within 
the first 10 minutes and over 75% within 40 minutes. Elemental analysis and magnetic 
hysteresis measurements confirm full particle recovery by simple magnetic separation. We 
demonstrate that magnetic separation-based blood purification offers rapid blood cleaning 
from noxious agents, germs or other deleterious materials with relevance in a number of 
clinical conditions. Based on this new approach, today’s blood purification can be extended to 
efficiently remove disease-causing factors, e.g. overdosed drugs, bacteria or cancer cells 
without being limited by filter cut-offs or column surface saturation. 
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Introduction 
While current therapeutic approaches are mostly based on the principle of antagonization or 
neutralization of a particular compound, elimination of the disease-causing factors would 
represent the most direct conceivable treatment.[1] Procedures removing compounds are 
routinely performed in patients suffering from renal insufficiency, where waste products are 
cleared by hemodialysis or hemofiltration.[2]  However, the use of size selective separation 
limits the applicability of such techniques to mostly low-molecular weight compounds, e.g., 
potassium, urea and creatinine. With continuing identification of new disease-causing factors 
with higher molecular weight, i.e. proteins, antibodies or endotoxins, there is a great demand 
for new technological solutions to access these compounds.[3] Recently, we and others have 
proposed a highly selective separation of target compounds from whole blood using 
functionalized magnetic nanoparticles.[4-6] In the magnetic blood purification process, 
circulating target compounds bind to capturing agents immobilized on tiny magneto-
responsive particles before the loaded nanoparticles are re-collected by magnetic separation.  
In contrast to classical purification processes using membranes or porous adsorbents, 
nanoparticles offer a high external surface area where capturing agents (e.g. antibodies) can 
be immobilized at a high density on the outermost surface layer, avoiding pore diffusion and 
providing excellent accessibility for the target.[7, 8] This geometry translates into highly 
efficient fluid purification, even for high molecular weight compounds with low diffusivity. 
In vitro removal of heavy metal ions (lead,[6, 9] cadmium,[10]  uranyl ions[5]), small molecule 
drugs (diazepam,[4] digoxin[6]), endotoxins,[11, 12]  inflammatory mediators[6, 13] or cells[14, 15] 
from plasma or whole blood samples has been reported. However, (long-term) risks and 
possible side effects associated with the use of nanoparticles in vivo are not yet completely 
understood.[16-19] Hence, an extracorporeal setting is preferred at this stage as it prevents 
nanoparticles from entering the body through the blood circuit: Nanoparticles are injected into 
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an extracorporeal loop to promote removal of target compounds. Prior to re-circulation of the 
blood into the body, a magnetic trap collects the particles, allowing for a continuous 
extracorporeal blood cleaning process.[13] Although the number of in vitro studies 
investigating the removal of compounds from whole blood by magnetic separation has 
increased rapidly in the last five years,[20] the concept has not yet been translated into an in 
vivo model.  The implementation into a feasible in vivo process has most likely been 
constrained by the use of weakly magnetic particles hampering recovery, and the limited 
blood circulation time of intravascularly applied nanoparticles.[21] In addition, blood 
coagulation issues and the limited blood volume of rodents may have prevented rapid 
advances in the field.[22] Here, we present an in vivo magnetic blood purification rodent animal 
model and demonstrate its ability to rapidly clear toxins from blood circulation. Based on this 
new technology, new therapeutic targets may be accessed by blood purification. 
 
 
Results and Discussion 
In this work, for the first time we show the successful implementation of a magnetic 
nanoparticle-based blood purification technology in a rodent animal model. As both the 
surface loading (number of functional groups per surface unit) and recovery of magnetic 
particles are key determinants critical to the process efficiency, ultra-strong magnetic 
nanoparticles with non-oxidic iron cores are used as magnetic carriers.  
Synthesis and Properties of Functionalized Nanomagnets. Carbon-encapsulated platinum-
spiked iron carbide (C/Fe3C) nanomagnets were synthesized using a flame spray synthesis 
process.[23] Addition of acetylene (C2H2) to the flame enabled in situ carbon-coating of the 
nanoparticles thus preventing oxidation of the iron-based core and corresponding loss of 
magnetism. Synthesized nanomagnets are highly magnetic with saturation magnetizations of 
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~123 emu/g.  Platinum is used as tracer to facilitate particle detection by elemental analysis 
even in complex and iron-rich matrices. The outermost carbon layer surrounding the highly 
magnetic core was covalently functionalized with target-specific capturing moieties. In this 
first experimental demonstration, heavy metal ions (lead, Pb2+) and digoxin (small molecule 
drug) served as model compounds having stable plasma levels and commercially available 
capturing moieties (iminodiacetic acid-based chelator and digoxin antibody FAB (digiFAB)) 
(Figure 1). Nanomagnets carrying target-specific capturing agents were dispersed in saline, a 
physiological carrier fluid to enable continuous injection into the circulating blood.  
Extracorporeal Magnetic Separation-based Blood Purification in Rats. Male Wistar rats 
with an estimated total blood volume of 25 mL were intoxicated by intravenous 
administration of the target toxin (lead (0.16 mg/kg) or digoxin (0.01 mg/kg)). The left carotid 
artery was catheterized and connected through extracorporeal tubing to the left external 
jugular vein (Figure 2a). The tubing and catheters were previously flushed with heparin. 
Blood was pumped through the extracorporeal circuit with a total extracorporeal volume of 
2.8 mL at a flow rate of 1.5 mL/min and functionalized magnetic nanoparticles were 
continuously injected into the circulating blood through a silicone injection port at a flow rate 
of 0.75 mg/min to reach a final concentration of 0.5 mg nanoparticles per mL blood, i.e. about 
30 mg in total for one experiment. Before the blood entered the external jugular vein, the 
nanomagnets were collected and separated from the re-circulating blood by a magnetic 
separation unit (gradient field induced by a permanent magnet). Animals undergoing the same 
procedure without injection of functionalized nanomagnets but of pure saline instead served 
as controls to account for variations in plasma concentration due to dilution (extra volume 
added by nanomagnet injection) and tissue accumulation/metabolism/excretion. During the 
experiment, blood samples were sequentially collected every ten minutes and analyzed for 
remaining toxin concentrations by well-established assays used in clinical diagnostics.[24, 25] 
    
6 
 
 
Toxin Concentration Measurements. Lead ion plasma levels were found significantly 
decreased in animals undergoing magnetic separation based blood purification using target-
specific nanomagnets compared to saline treated control animals (lead: p<0.01, N=5) (Figure 
2b). An additional control experiment using non-functionalized nanomagnets (no binding 
sites for lead ions) demonstrated a complete lack of purification. Similarly, digoxin could be 
rapidly removed from blood using digoxin-specific nanomagnets (p=0.0286, N=5) (Figure 
2c). For both model compounds, over 40% of the toxin was removed within the first 10 
minutes (p<0.001) and over 75% within 40 minutes. Toxin plasma levels in control animals 
remained relatively stable over a time period of 40 minutes, with a decrease by 10% for lead 
and 32% for digoxin, respectively.  
Magnetic Separation of Nanomagnets before Blood Recirculation. To verify how 
efficiently nanomagnets were eliminated from the blood stream, blood was collected after the 
magnetic separation unit and analyzed for residual particle concentration measuring the 
platinum content after chemical digestion by inductively coupled plasma-mass spectrometry 
(ICP-MS). The platinum concentration in the blood sample after the magnetic separation unit 
was found below limits of detection (detection limit of platinum in whole blood: ≤1 ng 
platinum per mL corresponding to ≤1 µg nanoparticles per mL blood) (Figure 2d). Analysis 
of magnetic properties of whole blood samples, i.e. hysteresis measurements, showed that 
blood before the magnetic separation unit exhibited ferromagnetic properties while after the 
separation unit, blood samples were diamagnetic (Figure 2e). This discrete change in 
properties is in good agreement with elemental analysis and confirms the high separation 
efficiency using a magnetic separator with simple geometry. Thus, magnetic measurements, 
in contrast to elemental analysis, enable identification of the iron phase of interest (i.e. intact 
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nanomagnets) without the need of chemical digestion, and differentiation between 
nanomagnets and dissolved iron.  
Safety Issues – What happens if the Magnetic Separation fails? To address safety issues 
concerning incomplete removal of nanomagnets, we analyzed tissue from animals after 
treatment with nanomagnets which were removed by the separator unit. Organs, particularly 
the liver with its phagocytic activity, were collected and analyzed for accumulated 
nanomagnets originating from potentially incomplete nanoparticle separation by the magnetic 
separation unit. Histological analysis of liver tissue visually confirmed the absence of 
nanoparticles (Figure 3). In contrast, when the worst case scenario was explored by omission 
of the separation unit for 15 minutes, analysis of lung and liver tissue samples showed 
significant accumulation of particles. Hence, extracorporeal application remains the preferred 
setting in terms of accessibility, efficiency and safety. 
 
 
Conclusions 
 
In summary, we present an easily applicable implementation of a nanomagnet-based blood 
purification process in a first in vivo detoxification model. Blood can be successfully purified 
in an extracorporeal blood purification circuit using functionalized nanomagnets as capturing 
moieties. Remarkable separation efficiencies are achieved even by a simple magnetic 
separation unit using a single permanent magnet. Hence, in vivo magnetic separation-based 
blood purification is a potent new method to selectively remove noxious compounds from 
blood not limited by size-selection criteria. This new technological solution provides the basis 
for new therapeutic targets and may be extended to selectively isolate disease causing factors 
such as overdosed drugs, proteins, endotoxins, bacteria (e.g. in sepsis) or cancer cells in a 
clinical setting.  
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The extracorporeal application of nanoparticles can be considered as a first step towards a 
safe implementation of nanomagnet-based treatments provided that safety barriers are 
implemented. Iron-based particle detection in complex and iron-rich matrices presents a major 
challenge even for the best available elemental analytics devices. Magnetic hysteresis 
measurements offer a valuable alternative complementing elemental analysis without 
requiring nanoparticle digestion. With regard to a future clinical application, the magnetic 
separation efficacy is pivotal: a safe implementation of this young technology relies on 
minimal risk policy by limiting direct exposure to nanomagnets and a detailed risk evaluation. 
This includes assessment of acute and long-term adverse effects and more advanced particle 
detection methods. [1, 26, 27] 
 
 
Materials and Methods 
Synthesis and characterization of carbon encapsulated platinum-spiked iron carbide 
nanomagnets: Carbon encapsulated platinum-spiked iron carbide nanomagnets were 
synthesized using flame spray synthesis under reducing atmosphere (detailed synthesis 
procedure can be found elsewhere) [28]. Briefly, iron and platinum precursors were 
synthesized by dissolving iron nitrate and platinum acetylacetonate in 2-ethylhexanoic acid, 
respectively. The precursors were mixed to have a mass content of 0.1% platinum, diluted 
with tetrahydrofurane (THF, Fluka, technical grade, 2:1) and filtered. Carbon encapsulated 
platinum-spiked iron carbide nanoparticles were synthesized in a flame spray synthesis 
reactor under nitrogen atmosphere. The precursor was fed into the spray nozzle at a flow rate 
of 6 mL/min. Acetylene (Pangas) was added at a flow rate of 5 L/min to obtain in situ coating 
of the nanoparticles. As-prepared nanoparticles were thoroughly washed in 24 vol% 
hydrochloric acid (HCl, Fluka, puriss) to dissolve incompletely coated nanoparticles. The 
platinum content was measured using inductively coupled plasma mass spectrometry (ICP-
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MS, Element2, Thermo-Finnigan, Bremen, Germany)  Magnetic hysteresis measurements 
were performed on a vibrating sample magnetometer (VSM, Princeton Measurements 
Corporation, model 3900) using a 100 ms averaging time. 
Chemical functionalization: For lead-ion selective functionalization, nanomagnets were 
coated with poly(ethylene imine) (PEI)-iminodiacetic acid (IDA). Before branched PEI (10 
kDa, Polysciences Inc., 99%) was physisorbed on the carbon shell encapsulating the 
nanoparticles, the particles were washed in H2O (Millipore) and DMF (Fluka, puriss), 
respectively. PEI was dissolved in dimethylformamide (DMF), added to nanoparticles pre-
dispersed in DMF and stirred overnight. Then, the nanoparticles were washed in DMF, water 
and acetone (Fluka, puriss) three times each and dried in vacuum. Subsequently, nanoparticles 
(100 mg) were dispersed in DMF (100 mL), and potassium hydroxide (0.2 g, Sigma Aldrich) 
and bromoacetic acid (0.1 g, Sigma Aldrich) were added. The mixture was stirred at 90°C-
110°C and 5 mL of H2O were added.  Nanoparticles were separated from the dispersion, 
washed and characterized using infrared spectroscopy (identification of functional groups, 
Fourier transform IR (FTIR) using a Tensor 27 Spectrometer (Bruker Optics, equipped with a 
diffuse reflectance accessory, DiffusIR, Pike technologies), and elemental analysis 
(quantitative analysis of carbon and nitrogen content, LECO, CHN-900). For anti-digoxin 
functionalization, nanomagnets were functionalized with thiol moieties, and then crosslinked 
with digiFAB using a heterobifunctional crosslinker (MAL-dPEG24-NHS, Quantabiodesign). 4 
Implementation of the extracorporeal blood circuit in Wistar rats: An extracorporeal circuit 
was assembled using tygon tubing with an ID of 3 mm and a length of 40 cm. A silicone 
injection port for nanoparticle-injection was connected. Both tube endings were connected to 
fine bore polyethylene catheters (0.58 mm ID, 0.96 mm OD) using 23G needles. The 
extracorporeal circuit was flushed with saline containing heparin (500U/mL) prior to 
operation of the animals. 
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Animal experiments were performed in accordance with Swiss Federal Animal Regulations 
and approved by the Veterinary Office of Zurich, Switzerland (No. 157/2011). Male Wistar 
rats weighing 350–500 g (Charles River, Sulzfeld, Germany) were used. The rats were housed 
in standard cages at 22°±1°C under a 12/12-h light–dark regimen. Food and water were 
supplied ad libitum. Rats were weighed and anesthetized with 3% isoflurane (Attane, Minrad 
Inc., Buffalo, NY, USA).  The ventral surface of the neck area, off midline and just above the 
external jugular vein, was shaved, cleaned, and de-germed.  A small incision  was made for 
access and cannulation of the left carotid artery left and the external jugular vein.  Both artery 
and vein were surgically exposed and two sutures (6-0 silk), proximal and distal, were placed 
around the vessels.  First, the distal suture of the carotid artery was retracted followed by a 
small incision into the ventral vessel wall, where the catheter was inserted and stabilized using 
the second silk suture. Blood was pumped into the extracorporeal circuit (pump from H.J. 
Guldener, Zurich, ZU/83W, 12082). The opponent ending of the tubing system was inserted 
into the external jugular vein and blood was pumped through the circuit at a flow rate of 1.5 
mL/min. Flow conditions and the total extracorporeal volume were adapted from Adachi et al. 
[29, 30]. Experimental groups include at least five animals each (N=5). 
Toxin concentration measurements: The first blood sample was collected 10 minutes after 
intravenous administration of the toxin in the jugular vein before magnetic blood purification 
was started. Subsequently, blood samples of 0.5 mL were collected every 10 minutes. Blood 
samples were analyzed for remnant toxin concentrations using Atomic Absorption 
Spectrometry (AAS) for lead ions [24] and a kinetic interaction of microparticles in solution 
assay (KIMS, Roche Diagnostics) for digoxin [25]. 
Nanoparticle concentration measurements: Nanoparticle residues were determined using two 
complementary methods, elemental analysis and magnetic hysteresis measurements. For ICP-
MS measurements (Element2, Thermo Fisher Scientific, Bremen), biological samples (blood 
and tissues) were digested using hydrochloric acid (conc.), nitric acid (conc.), hydrogen 
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peroxide (30%) at 200 °C and 40 bar ensuring total dissolution of all particles and the 
biological matrix. Platinum contents were then determined using ICP-MS. Magnetic 
hysteresis measurements of freeze-dried blood samples (CHRIST Alpha 1-4 freeze dryer, 
<0°C/<6.1 mbar) were performed on a vibrating sample magnetometer (VSM, Princeton 
Measurements Corporation, model 3900) using a 100 ms averaging time. 
Histology: In all groups, following blood purification, organs were procured and lung and 
liver tissue was analyzed using standard formalin fixation and H&E staining methods.  
Statistics: Plasma concentrations of toxins and nanoparticle concentrations are plotted as 
means ± standard deviation. Plasma concentrations were compared based on area under the 
curve (AUC) values using Mann-Whitney-U tests in SPSS.  
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Figures 
Figure 1 
 
 
Figure 1: Nanoparticle synthesis, characterization and functionalization. Platinum-spiked 
carbon-encapsulated iron carbide nanoparticles are synthesized in a flame spray synthesis 
setting under reducing atmosphere (a). Transmission electron micrographs show core/shell 
geometry with a carbon layer surrounding the highly magnetic core (b, c). The carbon surface 
can be chemically functionalized using physisorbed poly(ethylene imine) and iminodiacetic 
acid (d) or thiol-moieties which can be crosslinked with antibody fragments using 
poly(ethylene glycol)-based crosslinker (e).  
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Figure 2 
 
Figure 2:  In vivo magnetic separation based blood purification (a). Rats were catheterized 
placing catheters into the left carotid artery and external jugular vein gaining access to the 
blood circuit. The catheters were connected to the extracorporeal purification assembly 
consisting of blood transfusion tubing, a silicone port for nanomagnet injection and a 
magnetic separation unit.  In magnetic blood purification experiments using target-specific 
nanomagnets, concentrations of lead (b) and digoxin (c) decreased rapidly compared to 
controls (Lead: p<0.01; Digoxin: p=0.0286). Unfunctionalized nanomagnets (no binding 
sites) were ineffective. Platinum content in blood samples after chemical digestion of the 
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platinum-spiked nanoparticles was below the detection limit (d). Magnetic hysteresis 
measurements confirm the high recovery of nanomagnets by the magnetic separation unit: 
before the magnetic separator, the blood exhibits ferromagnetic properties while after 
separation it is diamagnetic (e). 
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Figure 3 
 
Figure 3:  Histological examination of lung and liver from rats undergoing extracorporeal 
blood purification with or without magnetic separation of the nanomagnets before 
recirculation. If nanomagnets are separated prior to re-entry into the body, histological images 
show no accumulation of nanomagnets in tissue (a). If nanomagnets are not separated before 
re-entry into the body (no magnet), nanomagnets are detected in both lung and liver tissues 
(H&E staining) (b). 
 
  
 
 
 
